Harvard Heart Letter

Heart Beat: Safety of bypass drug questioned

Patients undergoing bypass surgery are often given a clotting drug. Two studies suggest that the risk of a post-surgery stroke, heart attack, or kidney failure is substantially higher after receiving one such drug, Trasylol.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »